A similar behavior in a different contest has been reported in patients undergoing colorectal cancer surgery who display an early reduction of ficolin-1, followed by a rebound at longer time points (up to 2 weeks) with no relation to CRP changes [38]. This evidence concerns the gene CRP and colorectal cancer.